Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1671 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Xoma Gets Two New Patents From USPTO

Xoma said that one of the patents covers methods of treating type 2 diabetes with high affinity antibodies and antibody fragments that bind to IL-1 beta, including Xoma